Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Business Development Consultant appointment

3 Jun 2015 08:28

RNS Number : 0577P
Kuala Limited
03 June 2015
 



3 June 2015

Kuala Limited

 

("Kuala" or the "Company")

 

Subscription by Galloway Limited

Appointment of Galloway Limited as Business Development Consultant

 

Kuala Limited ("Kuala"), the AIM listed investment company ("KUL") is pleased to announce the appointment of Galloway Limited ("Galloway") as its Business Development Consultant. Concurrent with its appointment Galloway has subscribed for a 1,439,751 new shares ("Subscription Shares") of the Company at a subscription price of 5.88 pence per share (raising total proceeds of £84,657.37).

 

Appointment of Galloway as Business Development Consultant

 

Kuala, which was recapitalised in November 2014 to evaluate potential acquisition opportunities in the natural resources and/or energy sector, has been evaluating multiple opportunities in the mining and oil & gas industries. However, given the current market conditions and the difficulty of a capital raise in connection with an investment or acquisition opportunity in the natural resources or energy sector, the Directors of the Company have approved the appointment of Galloway as the Company's Business Development Consultant.

 

Under the terms of a consulting agreement dated 2 June 2015 Galloway has agreed to provide procurement and due diligence services to the Company for a fixed period of 6 months in relation to potential investment and/or acquisition opportunities in the bio-tech and fintech sectors. Mr James Mellon is a life tenant of a trust which is the owner of Galloway, and Mr Mellon and Galloway bring considerable investment expertise in the early-stage technology industries.

 

As consideration for its services (and in lieu of all reasonable professional expenses incurred) the Company shall pay to Galloway a fixed fee of £65,278.00. The Company and Galloway Limited have agreed that these fees will be satisfied by the issue of 1,110,170 new shares of the Company to Galloway (the "Consideration Shares"), each with an implied price of 5.88 pence.

 

Should the Company choose to pursue any investment or acquisition outside the scope of its current investing policy (focussed on natural resources and energy) then it would seek to amend its investing policy with the approval of shareholders at a general meeting of shareholders and potentially make appropriate changes to the Board to provide relevant expertise.

 

Galloway is currently conducting technical and financial due diligence on a number of potential investment opportunities for the Company, and has travelled extensively meeting with management teams. Galloway expects to report to the Company on its due diligence conclusions within 60 days. A further announcement in this regard will be made in due course.

 

Subscription by Galloway Limited

 

Under the terms of a subscription letter dated 2 June 2015 Galloway has subscribed for 1,439,751 new shares of the Company at a subscription price of 5.88 pence per share (raising total proceeds of £84,657.37).

 

The subscription by Galloway is at the market price of the Company's ordinary shares on AIM on 8 May 2015 and represents a premium to the market price of the Company's shares on AIM at close of business on 2 June 2015 of 4.5 per cent. The estimated net asset value as at 2 June 2015 is 2.16 pence per ordinary share and therefore the new Subscription Shares are being issued at a premium of 172% to the estimated net asset value.

 

The placing was completed with Galloway concurrently with its appointment as the Company's Business Development Consultant and was regarded as an important step by both parties, underlining Galloway's support for the Company and its management, and its strong belief that the current market conditions present an excellent opportunity for the Company to secure an investment or acquisition opportunity in the near future that will add real shareholder value.

 

Post the allotment of Subscription Shares and Consideration Shares, Galloway will be interested in 4,551,229 ordinary shares representing 14.66% of the enlarged share capital.

 

 

Stephen Dattels, Chairman of Kuala commented:

 

"Market conditions make any investment in mining or oil and gas projects at this time high-risk. Whilst the Company continues to evaluate potential investment and/or acquisition opportunities, the engagement of Galloway, and its subscription, positions the Company to consider and review potential opportunities outside its current investing policy (subject to shareholder approval being received)."

 

Issued Shares

 

The Subscription Shares and the Consideration Shares are expected to be admitted to trading on or around 8 June 2015. Following the issue of the Subscription Shares and the Consideration Shares the number of ordinary shares in issue in the Company will increase to 31,050,939. For the purposes of the Financial Conduct Authority's Disclosure and Transparency Rules ("DTRs"), the issued ordinary share capital of the Company following this allotment consists of 31,050,939 ordinary shares with voting rights attached (one vote per share). There are no shares held in treasury. This total voting rights figure may be used by shareholders as the denominator for the calculation by which they will determine whether they are required to notify their interest in, or a change to their interest in, Kuala Limited under the DTRs.

 

Related Party Transaction

Galloway Limited is a significant shareholder in the Company and a related party (as defined by the AIM Rules). The Subscription Shares and the Consideration Shares are on the terms and conditions set out above and Galloway Limited will not be offered any beneficial arrangement.

 

The issue of 1,439,751 Subscription Shares and 1,110,170 Consideration Shares to Galloway Limited constitutes a related party transaction for the purposes of the AIM Rules. The Directors of the Company, having consulted with RFC Ambrian, the Company's nominated adviser, consider the terms of such subscription for shares by Galloway Limited to be fair and reasonable insofar as the shareholders of the Company are concerned.

-ends-

 

For further information please visit www.kualalimited.com or contact:

Kuala Limited

Elysium Fund Management Limited

 

Tel: Tel: +44 1481 810 100

RFC Ambrian Limited (Nomad and Joint Broker)

 Samantha Harrison / Stephen Francavilla

 

Tel: +44 (0) 20 3440 6800 

Peterhouse Corporate Finance Limited (Joint Broker)

Guy Miller / Lucy Williams

 

Tel: +44 (0) 20 7469 0930

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGRGDLIDGBGUX
Date   Source Headline
23rd Jul 20187:00 amRNSAgreement
19th Jul 201812:40 pmRNSFurther investment in Intensity Therapeutics Inc.
9th Jul 201811:17 amRNSIncreased holding in Fralis LLC (Leap Gaming)
6th Jul 20185:44 pmRNSResults for the year ended 31st March 2018
22nd Jun 20182:30 pmRNSInvestment in Vogogo Inc. Conv. Debenture Units
20th Jun 20186:20 pmRNSInvestee Company Update
19th Jun 20187:00 amRNSInvestment in Juvenescence Limited
12th Jun 20187:00 amRNSInvestee Company Update: Subscription into Fralis
11th Jun 20189:53 amRNSSale of Aphria Shares
16th May 20187:00 amRNSRegulatory Approval
23rd Mar 20183:35 pmRNSInvestee Company Update: Nuuvera Inc.
21st Mar 20181:28 pmRNSInvestee Company Update: Nuuvera
12th Mar 20181:00 pmRNSKey Investor Document
7th Mar 20182:34 pmRNSDirector/PDMR Shareholding
7th Mar 20187:00 amRNSProposed Director's Dealing
27th Feb 20183:43 pmRNSInvestee Company Update: Intensity Therapeutics
26th Feb 20184:01 pmRNSInvestee Company Update: Nuuvera
20th Feb 20183:26 pmRNSInvestee Company Update: Nuuvera
13th Feb 201812:22 pmRNSDirector Appointment
13th Feb 201812:05 pmRNSResult of AGM
12th Feb 20184:51 pmRNSTransaction in Own Shares
6th Feb 20189:37 amRNSCorrection of Notice of AGM
2nd Feb 20189:35 amRNSInvestee Company Update: Vemo
31st Jan 201811:04 amRNSTransaction in Own Shares
30th Jan 20185:00 pmRNSNotice of AGM
30th Jan 20184:20 pmRNSNotice of AGM
30th Jan 20188:35 amRNSHolding(s) in Company
29th Jan 20181:33 pmRNSInvestee Company Update: Nuuvera
23rd Jan 20182:43 pmRNSExtension of Share Buy-back Programme
23rd Jan 20181:19 pmRNSTransaction in Own Shares
18th Jan 20183:18 pmRNSInvestment Company Updates: Nuuvera
16th Jan 20183:36 pmRNSInvestee Company Update: Nuuvera
12th Jan 20183:43 pmRNSInvestee Company Update: Nuuvera
12th Jan 20182:23 pmRNSInvestee Company Update: Nuuvera
11th Jan 20188:00 amRNSInvestee Company Update: Nuuvera
8th Jan 20187:00 amRNSInvestee Company Update: Nuuvera
2nd Jan 201811:26 amRNSInvestee Company update: Nuuverra transaction
28th Dec 20173:29 pmRNSHalf-year Report
15th Dec 20179:23 amRNSCompany Secretary Change
15th Dec 20177:00 amRNSInvestee Company Update: Nuuvera
29th Nov 20174:14 pmRNSTransaction in Own Shares
29th Nov 20177:00 amRNSHolding(s) in Company
28th Nov 20174:06 pmRNSTransaction in Own Shares
23rd Nov 201710:12 amRNSHolding(s) in Company
20th Nov 201710:30 amRNSShare Buy-Back Programme
20th Nov 20179:56 amRNSMarket Update
3rd Nov 201712:00 pmRNSInvestee Company Update
9th Oct 20177:00 amRNSUpdate on Nuuverra Investment
18th Sep 20177:00 amRNSDisposal of interest in investee company
15th Aug 20177:00 amRNSInvestee Company Update: Schoold

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.